Clinical Trial Update: Effect of Topical Botulinum Toxin Eyedrop on Palpebral Fissure [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating a topical botulinum toxin eyedrop for excessive tearing and eyelid spasm was terminated, with results posted on 2024-12-05.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Blepharospasm
• Epiphora

Drugs mentioned

• Topical Botulinum Toxin Eyedrop

Snippet

Sponsor: University of Miami | Conditions: Tears; Excess, Eyelid Spasm | Phase 4 | Status: TERMINATED | Results posted: 2024-12-05